Announce Date | 05/08/2025 |
EPS Normalized Actual | $-0.18 (Miss by $-0.06) |
EPS GAAP Actual | $-0.18 (Miss by $-0.06) |
Revenue Actual | $8.979B |
Revenue Surprise | Beat by $8979M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.26874 | 41.75 | 0.2509 | 0.2822 | 5 |
Dec 2025 | 0.32623 | 34.39 | -0.46 | 1.46755 | 11 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.18 | -0.18 | 8.979B | -10.9% | 8979M |
FQ4 2024 (Dec 2024) | 4.42 | 4.42 | 10.033B | -2.55% | 10033M |
FQ3 2024 (Sep 2024) | -0.0012 | -0.0012 | 9.623B | -3.7% | 9623M |
FQ2 2024 (Jun 2024) | -4.07 | -4.07 | 9.711B | -6.66% | 9711M |
FQ1 2024 (Mar 2024) | -0.28 | -0.28 | 9.958B | -7.45% | 9958M |
FQ4 2023 (Dec 2023) | -0.16 | -0.16 | 10.289B | -6.99% | 10289M |
FQ3 2023 (Sep 2023) | -0.0008 | -0.0008 | 9.979B | 1.56% | 9979M |
FQ2 2023 (Jun 2023) | -0.0016 | -0.0016 | 10.358B | 5.13% | 10358M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 0 | -- | 0 | 0 | 0 |
FQ3 2029 (Sep 2029) | 0 | -- | 0 | 0 | 2 |
FQ2 2029 (Jun 2029) | 0 | -- | 0 | 0 | 2 |
FQ1 2029 (Mar 2029) | 0 | -- | 0 | 0 | 2 |
FQ4 2028 (Dec 2028) | 0 | -- | 0 | 0 | 5 |
FQ3 2028 (Sep 2028) | 0 | -- | 0 | 0 | 9 |
FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 6 |
FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 5 |
FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 4 |
FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 3 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 3 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 12.66B | -- | 12.23B | 13.09B | 4 |
FQ3 2029 (Sep 2029) | 10.56B | -- | 10.16B | 10.94B | 4 |
FQ2 2029 (Jun 2029) | 10.79B | -- | 10.38B | 11.18B | 5 |
FQ1 2029 (Mar 2029) | 10.99B | -- | 10.58B | 11.39B | 4 |
FQ4 2028 (Dec 2028) | 11.55B | -- | 11.14B | 12.08B | 6 |
FQ3 2028 (Sep 2028) | 10.76B | -- | 10.38B | 11.26B | 10 |
FQ2 2028 (Jun 2028) | 10.5B | -- | 10.12B | 10.98B | 6 |
FQ1 2028 (Mar 2028) | 10.76B | -- | 10.38B | 11.26B | 12 |
FQ4 2027 (Oct 2027) | 11.32B | -- | 10.76B | 11.89B | 6 |
FQ3 2027 (Jul 2027) | 12.06B | -- | 11.47B | 12.67B | 6 |
FQ2 2027 (Jun 2027) | 12.06B | -- | 11.35B | 12.68B | 6 |
FQ1 2027 (Mar 2027) | 11.72B | -- | 11.15B | 12.31B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.18 | -0.18 | 100% | |
FQ4 2024 (Dec 2024) | 4.42 | 4.42 | 100% | |
FQ3 2024 (Sep 2024) | -0.0012 | -0.0012 | 100% | |
FQ2 2024 (Jun 2024) | -4.07 | -4.07 | 100% | |
FQ1 2024 (Mar 2024) | -0.28 | -0.28 | 100% | |
FQ4 2023 (Dec 2023) | -0.16 | -0.16 | 100% | |
FQ3 2023 (Sep 2023) | -0.0008 | -0.0008 | 100% | |
FQ2 2023 (Jun 2023) | -0.0016 | -0.0016 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $8.98B | $8979M | 100% |
FQ4 2024 (Dec 2024) | $0B | $10.03B | $10033M | 100% |
FQ3 2024 (Sep 2024) | $0B | $9.62B | $9623M | 100% |
FQ2 2024 (Jun 2024) | $0B | $9.71B | $9711M | 100% |
FQ1 2024 (Mar 2024) | $0B | $9.96B | $9958M | 100% |
FQ4 2023 (Dec 2023) | $0B | $10.29B | $10289M | 100% |
FQ3 2023 (Sep 2023) | $0B | $9.98B | $9979M | 100% |
FQ2 2023 (Jun 2023) | $0B | $10.36B | $10358M | 100% |